4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-013472
CEO sold 3,851 shares at $18.78 ($72,322)
- CEO acquired 10,945 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2023-02-23 | Option exercise | +10,945 | 95,578 | D | ||
| DAVIS STEPHEN CEO | 2023-02-24 | Sale | −3,851 | $18.78 | $72,322 | 91,727 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2023-02-23 | Option exercise · Restricted Stock Units | −10,945 | 21,892 | D | ||
| Open-market sales · 3,851 sh · avg $18.78 · $72,322 | |||||||
Loading xslF345X03/doc4.xml…